HomeZNTL • NASDAQ
add
Zentalis Pharmaceuticals Inc
Previous close
$11.96
Day range
$11.62 - $12.26
Year range
$9.56 - $31.46
Market cap
857.13M USD
Avg Volume
663.52K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | 40.56M | — |
Operating expense | 65.32M | 0.57% |
Net income | 10.07M | 115.93% |
Net profit margin | 24.82 | — |
Earnings per share | 0.14 | 113.08% |
EBITDA | -24.44M | 62.16% |
Effective tax rate | 1.40% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 488.98M | 24.58% |
Total assets | 557.48M | 13.92% |
Total liabilities | 98.71M | -4.79% |
Total equity | 458.77M | — |
Shares outstanding | 71.01M | — |
Price to book | 1.85 | — |
Return on assets | -11.16% | — |
Return on capital | -12.54% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | 10.07M | 115.93% |
Cash from operations | -51.97M | -5.46% |
Cash from investing | 61.54M | 46.11% |
Cash from financing | 7.00K | -98.12% |
Net change in cash | 9.58M | 241.08% |
Free cash flow | -18.07M | 39.81% |
About
Founded
2014
Website
Employees
124